Relapse of sarcoidosis upon treatment with etanercept

Relapse of sarcoidosis upon treatment with etanercept

Tumour necrosis factor (TNF)-α is thought to play a central role in promoting and perpetuating inflammation in sarcoidosis, and treatment with TNF-α inhibitors has been reported to be successful. 1 - 3 We present a patient with quiescent sarcoidosis who relapsed shortly after beginning treatment w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2008-06, Vol.67 (6), p.896-898
Hauptverfasser: Louie, G H, Chitkara, P, Ward, M M
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Antirheumatic Agents - adverse effects
Back pain
Biological and medical sciences
Diseases of the osteoarticular system
Etanercept
Female
Humans
Immunoglobulin G - adverse effects
Immunomodulators
Medical sciences
Patients
Pharmacology. Drug treatments
Receptors, Tumor Necrosis Factor
Recurrence
Sarcoidosis
Sarcoidosis - chemically induced
Sarcoidosis - complications
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Spondylitis, Ankylosing - complications
Spondylitis, Ankylosing - drug therapy
Tomography
Tumor necrosis factor-TNF
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Tumour necrosis factor (TNF)-α is thought to play a central role in promoting and perpetuating inflammation in sarcoidosis, and treatment with TNF-α inhibitors has been reported to be successful. 1 - 3 We present a patient with quiescent sarcoidosis who relapsed shortly after beginning treatment with a TNF-α inhibitor for an unrelated medical condition.
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.2007.078840